Adult pancreatic islet endocrine cells emerge as fetal hormone-expressing cells

Cell Rep. 2022 Feb 15;38(7):110377. doi: 10.1016/j.celrep.2022.110377.

Abstract

The precise developmental dynamics of the pancreatic islet endocrine cell types, and their interrelation, are unknown. Some authors claim the persistence of islet cell differentiation from precursor cells after birth ("neogenesis"). Here, using four conditional cell lineage tracing ("pulse-and-chase") murine models, we describe the natural history of pancreatic islet cells, once they express a hormone gene, until late in life. Concerning the contribution of early-appearing embryonic hormone-expressing cells to the formation of islets, we report that adult islet cells emerge from embryonic hormone-expressing cells arising at different time points during development, without any evidence of postnatal neogenesis. We observe specific patterns of hormone gene activation and switching during islet morphogenesis, revealing that, within each cell type, cells have heterogeneous developmental trajectories. This likely applies to most maturating cells in the body, and explains the observed phenotypic variability within differentiated cell types. Such knowledge should help devising novel regenerative therapies.

Keywords: CRISPR; cell lineage tracing; development; diabetes; hormone; insulin gene expression; islet; pancreas; pulse-and-chase; transgenic mouse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology*
  • Animals
  • Doxycycline / pharmacology
  • Embryonic Development / drug effects
  • Fetus / cytology*
  • Fetus / drug effects
  • Gene Expression Regulation, Developmental / drug effects
  • Glucagon / metabolism
  • Hormones / metabolism*
  • Islets of Langerhans / cytology*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / embryology*
  • Mice, Transgenic
  • Somatostatin / metabolism
  • Staining and Labeling

Substances

  • Hormones
  • Somatostatin
  • Glucagon
  • Doxycycline